Connor, Clark & Lunn Investment Management (CC&L)
IRON icon

Connor, Clark & Lunn Investment Management (CC&L)’s Disc Medicine IRON Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17,952
Closed -$1.12M – 1523
2024
Q1 		$1.12M Sell
17,952
-7,105
-28% -$461K ﹤0.01% 850
2023
Q4 		$1.45M Buy
25,057
+8,415
+51% +$431K 0.01% 750
2023
Q3 		$782K Buy
+16,642
New +$832K ﹤0.01% 899

Other funds holding IRON

PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s IRON Position: Q2 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Disc Medicine (IRON) in Q2 2024, closing a stake of 17,952 shares — an estimated $1.12M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in IRON in Q3 2023 and held it in 3 quarters. The position peaked at $1.45M in Q4 2023. 121 funds tracked by Wall St. Rank hold IRON as of Q2 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Disc Medicine position as of Q2 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 17,952 Disc Medicine shares in Q2 2024, an estimated $1.12M.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Disc Medicine in Q3 2023 and held it in 3 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Disc Medicine position peaked at $1.45M in Q4 2023.
  • 121 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2024, filed 9 Aug 2024.